Prof Stephen Caddick
Professor of Organic Chemistry and Chemical Biology
Dept of Chemistry
Faculty of Maths & Physical Sciences
- Joined UCL
- 1st Oct 2003
Research summary
The Caddick group carries out research to: (a) Develop methods, and strategies for synthesis (including radicals, organometallics, sulfonamides, amino acids); (b) To develop molecules for utilisation as probes, diagnostic tools or as therapeutics (areas include Neocarzinostatin; (de)methyation enzymes; HIV transport; NMDA receptors; beta-receptors).
Teaching summary
Extensive experience of undergraduate and postgraduate lectures in medicinal chemistry, chemical biology and synthetic chemistry to year 1, 2, 3 and 4 at M.Chem / MSci & BSc level
Academic and Personal Tutor
Laboratory Course Demonstrating
Supervision of undergraduate and postgraduate research projects
Extensive experience of internal and external examining at u/g & p/g level
Education
- University of Southampton
- Doctorate, Doctor of Philosophy | 1989
- Cambridgeshire College of Arts and Technology
- First Degree, Graduate of the Royal Society of Chemistry | 1986
- Paisley College
- First Degree, Bachelor of Science | 1984
Biography
Professor Caddick was appointed as Vice-Provost (Enterprise) in 2010, and is responsible to the Provost for leading UCL's enterprise agenda for the maximum societal and economic benefit including: knowledge transfer and exchange, business relationships and partnerships, entrepreneurship, innovation and social enterprise. He joined UCL in 2003 as Vernon Professor of Organic Chemistry and Chemical Biology and was appointed to develop the area of Chemical Biology as a major research strength.
He was the founding director of the Centre for Chemical Biology, head of the Organic and Chemical Biology group and, most recently, Head of the Department of Chemistry. Professor Caddick has a major research group in Organic Synthesis and Chemical Biology with a particular focus on the development of novel and sustainable synthetic methods for applications in biological and biomedical research. In recent times his group has developed new methods for the chemical modification of proteins, and for making diverse collections of chemical compounds which can be used to dissect biological pathways and have potential as therapeutics. His research is highly collaborative with academic and industrial partners, and is funded by UK research councils, the Wellcome Trust, and several major pharmaceutical companies.
Professor Caddick has served on a number of EPSRC, BBSRC and MRC funding panels and committees and is currently a member of the MRC's DPFS panel and MRCT's Drug Discovery Advisory Board. He is currently playing a key role in developing the unique contribution UCL will make to the UK Centre for Medical Research & Innovation (UKCMRI), which will bring the university together with three other world-leading biomedical research organisations (Cancer Research UK, the Medical Research Council and the Wellcome Trust) in central London to undertake cutting-edge research and training of medical scientists to advance our understanding of health and disease.